Table 3.
Control | Cuffs |
ANOVA table (condition, time, condition by time) |
|||
---|---|---|---|---|---|
BDC-2 | R+1 | BDC-2 | R+1 | ||
AMT (μm) | 270.1 ± 20.5 | 267.2 ± 17.2 | 269.9 ± 14.6 | 268.4 ± 16.1 | P = 0.948, P = 0.339, P = 0.768 |
(254.3–285.8) | (254.0–280.5) | (257.8–282.1) | (255.0–281.9) | ||
GCC | |||||
Average (μm) | 102.8 ± 6.9 | 101.5 ± 7.0 | 97.8 ± 5.8 | 97.2 ± 5.0 | P = 0.139, P = 0.250, P = 0.684 |
(97.5–108.1) | (96.1–106.8) | (93.0–102.7) | (93.0–101.4) | ||
Superior (μm) | 101.1 ± 6.4 | 101.0 ± 7.8 | 96.4 ± 4.9 | 96.5 ± 6.1 | P = 0.149, P = 0.995, P = 0.924 |
(96.1–106.0) | (94.9–107.0) | (92.3–100.5) | (91.4–101.6) | ||
Inferior (μm) | 104.1 ± 7.4 | 101.9 ± 6.8 | 99.3 ± 7.3 | 97.9 ± 4.1 | P = 0.163, P = 0.104, P = 0.684 |
(98.4–109.9) | (96.7–107.1) | (93.2–105.3) | (94.5–101.3) | ||
RNFLT | |||||
Average (μm) | 103.3 ± 5.3 | 103.0 ± 8.7 | 99.4 ± 6.7 | 101.4 ± 9.8 | P = 0.488, P = 0.608, P = 0.470 |
(98.9–107.8) | (95.7–110.2) | (92.3–106.4) | (91.2–111.7) | ||
Temporal (μm) | 73.6 ± 9.1 | 75.3 ± 8.3* | 72.2 ± 9.3 | 75.7 ± 9.1†† | P = 0.922, P < 0.001, P = 0.119 |
(66.0–81.2) | (68.4–82.3) | (62.5–82.0) | (66.1–85.3) | ||
Superior (μm) | 126.3 ± 6.6 | 122.8 ± 6.9 | 123.7 ± 12.5 | 121.7 ± 14.1 | P = 0.716, P = 0.189, P = 0.726 |
(120.8–131.8) | (117.1–128.6) | (110.6–136.8) | (106.9–136.4) | ||
Nasal (μm) | 89.9 ± 18.0 | 87.2 ± 11.7 | 85.7 ± 14.3 | 80.6 ± 17.0 | P = 0.482, P = 0.316, P = 0.750 |
(74.9–104.8) | (77.3–97.0) | (70.7–100.7) | (62.7–98.4) | ||
Inferior (μm) | 124.5 ± 12.6 | 124.9 ± 17.3 | 122.3 ± 14.5 | 128.4 ± 9.1 | P = 0.917, P = 0.491, P = 0.541 |
(114.0–135.0) | (110.4–139.4) | (107.1–137.5) | (118.8–138.0) |
AMT, average macular thickness; BDC-2, 2 days before DI; GCC, ganglion cell complex; RNFLT, retinal nerve fiber layer thickness; R+1, first day after DI. Values in parentheses represent 95% CI of the mean.
P < 0.05 vs. BDC-2 in control group,
P < 0.01 vs. BDC-2 in cuffs group.